Quick Order

CD22 Antibody, Mouse MAb

    DatasheetReviewsRelated ProductsProtocols
    Human CD22 Antibody Product Information
    Immunogen:Recombinant Human CD22 protein (Catalog#11958-H08H)
    Clone ID:07
    Ig Type:Mouse IgG1
    Concentration:
    Endotoxin:
    Formulation:0.2 μm filtered solution in PBS with 5% trehalose
    Preparation:This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD22 (rh CD22; Catalog#11958-H08H; P20273-1; Met 1-Arg 687). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
    Other CD22 Antibody Products
    Reactivity: Human  
    Application: ELISA  
      11958-R340-50
      11958-R340-100
      50 µg 
      100 µg 
      Add to Cart
      Reactivity: Human  
      Application: ELISA  
        11958-RP01-400
        11958-RP01-200
        11958-RP01-100
         
        200 µg 
        100 µg 
        Add to Cart
        Reactivity: Mouse  
        Application: FCM  
        • Slide 1
        51177-R026-P-50
        51177-R026-P-100
        50 Tests 
        100 Tests 
        Add to Cart
        Reactivity: Mouse  
        Application: FCM  
        • Slide 1
        51177-R060-F-50
        51177-R060-F-100
        50 Tests 
        100 Tests 
        Add to Cart
        Reactivity: Mouse  
        Application: FCM  
        • Slide 1
        51177-R060-P-50
        51177-R060-P-100
        50 Tests 
        100 Tests 
        Add to Cart
        Reactivity: Mouse  
        Application: ELISA  
          51177-R064-100
          51177-R064-50
          100 µg 
          50 µg 
          Add to Cart
          Reactivity: Mouse  
          Application: WB  
          • Slide 1
          51177-R078-100
          51177-R078-50
          100 µg 
          50 µg 
          Add to Cart
          Reactivity: Mouse  
          Application: WB  IP  
          • Slide 1
          • Slide 1
          51177-R087-100
          51177-R087-50
          100 µg 
          50 µg 
          Add to Cart
          Reactivity: Mouse  
          Application: FCM  
          • Slide 1
          51177-R060-50
          51177-R060-100
          50 µg 
          100 µg 
          Add to Cart
          Reactivity: Rat  
          Application: ELISA  IHC-P  
          • Slide 1
          81343-T24-100
          81343-T24-50
          81343-T24-200
          100 µg 
          50 µg 
          200 µg 
          Add to Cart
          Reactivity: Rat  
          Application: ELISA  
            81343-RP01-200
            81343-RP01-100
            81343-RP01-400
            200 µg 
            100 µg 
             
            Add to Cart
            CD22/Siglec-2 Background

            CD22 is a member of the immunoglobulin superfamily, SIGLEC family of lectins. It is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. CD22 serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. In addition to its potential role as a mediator of intercellular interactions, signal transduction through CD22 can activate B cells and modulate antigen receptor signaling in vitro. The phenotype of CD22-deficient mice suggests that CD22 is primarily involved in the generation of mature B cells within the bone marrow, blood, and marginal zones of lymphoid tissues. CD22 recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and inhibits B-cell receptor (BCR)-induced Ca2+ signaling on normal B cells. CD22 interacts specifically with ligands carrying alpha2-6-linked sialic acids. As an inhibitory coreceptor of the B-cell receptor (BCR), CD22 plays a critical role in establishing signalling thresholds for B-cell activation. Like other coreceptors, the ability of CD22 to modulate B-cell signalling is critically dependent upon its proximity to the BCR, and this in turn is governed by the binding of its extracellular domain to alpha2,6-linked sialic acid ligands. However, genetic studies in mice reveal that some CD22 functions are regulated by ligand binding, whereas other functions are ligand-independent and may only require expression of an intact CD22 cytoplasmic domain at the B-cell surface. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity, while CD22 inhibits CD19 phosphorylation via SHP-1.

            Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

            Human CD22/Siglec-2 References
          • Tedder TF, et al. (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol. 15: 481-504.
          • Tedder TF, et al. (2005) CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction. Adv Immunol. 88: 1-50.
          • Fujimoto M, et al. (2007) B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci. 46(1): 1-9.
          • Walker JA, et al. (2008) CD22: an inhibitory enigma. Immunology. 123(3): 314-25.
          • Nitschke L. (2009) CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev. 230(1): 128-43.
          • Product nameProduct name
            Size / Price
            Catalog: 11958-MM07-200
            List Price: 
            Price:      (You Save: )

            Datasheet & Documentation

            All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
            Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"